drugset / Trial / NCT03427021

A Randomized Study to Establish the Efficacy of Oral Ice Exposure During Oxaliplatin Infusion in Preventing Oral Cold Sensitivity

NCT03427021

Phase 0 Terminated 65 enrolled Abramson Cancer Center at Penn Medicine
RandomizedParallel-groupOpen-labelTreatment

Summary

The main purpose of this study is to evaluate whether exposure to ice chips in the mouth (oral ice chips) during oxaliplatin treatment prevents or reduces symptoms of cold sensitivity.

Timeline

Start
2017-02-01
Primary completion
2018-10-23
Completion
2018-10-23

Drugs

EvaluationDrugModalityDoseRoute
Background Oxaliplatin Small molecule Other